Guided Therapeutics, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced operating loss was USD 823,000 compared to USD 242,000 a year ago. Net loss was USD 517,000 compared to net income of USD 2.728 million a year ago. Basic loss per share from continuing operations was USD 0.043 compared to basic earnings per share from continuing operations of USD 0.542 a year ago. Diluted loss per share from continuing operations was USD 0.043 compared to diluted earnings per share from continuing operations of USD 0.041 a year ago.